These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
130 related items for PubMed ID: 15355639
1. [Correlation of expression of RhoA (RhoC and their effector ROCK-1 with malignant phenotype of ovarian cancer cells in vitro]. Han ZQ, Zhang AL, Wu MF, Liu YL, Chen G, Li FJ, Gao QL, Liao GN, Lu YP, Wang SX, Ma D. Zhonghua Zhong Liu Za Zhi; 2004 Jul; 26(7):385-8. PubMed ID: 15355639 [Abstract] [Full Text] [Related]
2. RhoC expression level is correlated with the clinicopathological characteristics of ovarian cancer and the expression levels of ROCK-I, VEGF, and MMP9. Zhao Y, Zong ZH, Xu HM. Gynecol Oncol; 2010 Mar; 116(3):563-71. PubMed ID: 20022093 [Abstract] [Full Text] [Related]
4. Significant association of Rho/ROCK pathway with invasion and metastasis of bladder cancer. Kamai T, Tsujii T, Arai K, Takagi K, Asami H, Ito Y, Oshima H. Clin Cancer Res; 2003 Jul; 9(7):2632-41. PubMed ID: 12855641 [Abstract] [Full Text] [Related]
5. [Effect of blocking of ROCK-1, an effector of small G protein Rho, on the malignant behavior of ovarian tumor cells in vitro]. Han ZQ, Hong ZY, Hu CX, Hu Y, Chen CH, Lu YP, Wang SX, Zhou JF, Ma D. Zhonghua Zhong Liu Za Zhi; 2007 Oct; 29(10):723-7. PubMed ID: 18396681 [Abstract] [Full Text] [Related]
8. RhoA and RhoC -siRNA inhibit the proliferation and invasiveness activity of human gastric carcinoma by Rho/PI3K/Akt pathway. Sun HW, Tong SL, He J, Wang Q, Zou L, Ma SJ, Tan HY, Luo JF, Wu HX. World J Gastroenterol; 2007 Jul 07; 13(25):3517-22. PubMed ID: 17659701 [Abstract] [Full Text] [Related]
11. Clinical and prognostic significance of RhoA and RhoC gene expression in esophageal squamous cell carcinoma. Faried A, Faried LS, Usman N, Kato H, Kuwano H. Ann Surg Oncol; 2007 Dec 07; 14(12):3593-601. PubMed ID: 17896152 [Abstract] [Full Text] [Related]
12. IL-6 induces AGS gastric cancer cell invasion via activation of the c-Src/RhoA/ROCK signaling pathway. Lin MT, Lin BR, Chang CC, Chu CY, Su HJ, Chen ST, Jeng YM, Kuo ML. Int J Cancer; 2007 Jun 15; 120(12):2600-8. PubMed ID: 17304514 [Abstract] [Full Text] [Related]
13. Inhibitory effects of adenovirus mediated tandem expression of RhoA and RhoC shRNAs in HCT116 cells. Liu XP, Wang HB, Yang K, Sui AH, Shi Q, Qu S. J Exp Clin Cancer Res; 2009 Apr 18; 28(1):52. PubMed ID: 19374769 [Abstract] [Full Text] [Related]
15. [Correlation of expression of RhoC with invasiveness of breast cancer cells in vitro]. Yuan Z, Su J, You JF, Wang JL, Cui XL, Zheng J. Zhonghua Zhong Liu Za Zhi; 2007 Dec 18; 29(12):898-903. PubMed ID: 18478927 [Abstract] [Full Text] [Related]
17. Specific induction of migration and invasion of pancreatic carcinoma cells by RhoC, which differs from RhoA in its localisation and activity. Dietrich KA, Schwarz R, Liska M, Grass S, Menke A, Meister M, Kierschke G, Längle C, Genze F, Giehl K. Biol Chem; 2009 Oct 18; 390(10):1063-77. PubMed ID: 19642867 [Abstract] [Full Text] [Related]
18. RhoA/ROCK pathway mediates leptin-induced uPA expression to promote cell invasion in ovarian cancer cells. Ghasemi A, Hashemy SI, Aghaei M, Panjehpour M. Cell Signal; 2017 Apr 18; 32():104-114. PubMed ID: 28104444 [Abstract] [Full Text] [Related]